$307 Million is the total value of Endurant Capital Management LP's 49 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 86.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INVACARE CORPnote 5.000%11/1 | $49,063,000 | -1.9% | 56,727,000 | 0.0% | 15.98% | -8.9% | ||
| LH | Buy | LABORATORY CORP AMER HLDGS | $19,917,000 | +144.8% | 97,245 | +180.1% | 6.49% | +127.2% |
| HUM | Buy | HUMANA INC | $15,880,000 | +25.2% | 32,729 | +20.7% | 5.17% | +16.2% |
| TAK | New | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $14,297,000 | – | 1,102,280 | +100.0% | 4.66% | – |
| BAX | Buy | BAXTER INTL INC | $13,201,000 | +128.7% | 245,093 | +172.7% | 4.30% | +112.3% |
| QGEN | Sell | QIAGEN NV | $12,546,000 | -33.3% | 303,928 | -23.7% | 4.09% | -38.0% |
| LLY | New | LILLY ELI & CO | $12,388,000 | – | 38,311 | +100.0% | 4.04% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $12,323,000 | +472.4% | 145,374 | +459.7% | 4.01% | +431.5% |
| ICLR | Buy | ICON PLC | $12,210,000 | +13.3% | 66,437 | +33.6% | 3.98% | +5.2% |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $11,283,000 | – | 158,721 | +100.0% | 3.68% | – |
| CTLT | New | CATALENT INC | $10,136,000 | – | 140,077 | +100.0% | 3.30% | – |
| CI | Sell | CIGNA CORP NEW | $9,461,000 | -11.1% | 34,099 | -15.5% | 3.08% | -17.4% |
| OHI | New | OMEGA HEALTHCARE INVS INC | $9,253,000 | – | 313,762 | +100.0% | 3.01% | – |
| INVACARE CORPnote 5.000%11/1 | $8,438,000 | -8.8% | 10,097,000 | 0.0% | 2.75% | -15.3% | ||
| AZYO | Buy | AZIYO BIOLOGICS INC | $8,208,000 | +2.4% | 1,139,932 | +0.6% | 2.67% | -4.9% |
| BDX | New | BECTON DICKINSON & CO | $7,639,000 | – | 34,282 | +100.0% | 2.49% | – |
| ANTM | New | ELEVANCE HEALTH INC | $7,450,000 | – | 16,402 | +100.0% | 2.43% | – |
| ZTS | Buy | ZOETIS INCcl a | $6,567,000 | -7.0% | 44,286 | +7.8% | 2.14% | -13.7% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $6,459,000 | +6.9% | 3,938,409 | -14.6% | 2.10% | -0.7% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $5,541,000 | – | 101,048 | +100.0% | 1.80% | – |
| MCK | Buy | MCKESSON CORP | $5,495,000 | +5.4% | 16,168 | +1.2% | 1.79% | -2.1% |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $4,417,000 | +44.5% | 1,064,295 | +40.0% | 1.44% | +34.2% |
| EHC | New | ENCOMPASS HEALTH CORP | $3,751,000 | – | 82,929 | +100.0% | 1.22% | – |
| THC | Buy | TENET HEALTHCARE CORP | $3,638,000 | +45.9% | 70,535 | +48.7% | 1.18% | +35.4% |
| VTR | New | VENTAS INC | $3,442,000 | – | 85,683 | +100.0% | 1.12% | – |
| ALBO | Buy | ALBIREO PHARMA INC | $3,342,000 | +345.0% | 172,621 | +356.2% | 1.09% | +313.7% |
| BIO | Sell | BIO RAD LABS INCcl a | $2,913,000 | -63.3% | 6,984 | -56.4% | 0.95% | -65.9% |
| MMSI | Buy | MERIT MED SYS INC | $2,894,000 | +163.6% | 51,218 | +153.3% | 0.94% | +144.9% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $2,546,000 | +55.1% | 97,327 | +50.3% | 0.83% | +43.9% |
| INSM | Sell | INSMED INC | $2,320,000 | -17.2% | 107,713 | -24.2% | 0.76% | -23.1% |
| GLPG | Sell | GALAPAGOS NVspon adr | $2,167,000 | -24.5% | 50,822 | -1.1% | 0.71% | -29.8% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $1,923,000 | -38.0% | 1,788,517 | -1.9% | 0.63% | -42.5% |
| CANO | New | CANO HEALTH INC | $1,829,000 | – | 210,915 | +100.0% | 0.60% | – |
| VCYT | New | VERACYTE INC | $1,805,000 | – | 108,751 | +100.0% | 0.59% | – |
| AVTR | Sell | AVANTOR INC | $1,489,000 | -89.4% | 75,948 | -83.2% | 0.48% | -90.1% |
| STRO | Sell | SUTRO BIOPHARMA INC | $1,480,000 | -20.5% | 266,679 | -25.4% | 0.48% | -26.2% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $1,446,000 | -58.2% | 179,226 | -61.0% | 0.47% | -61.2% |
| OPCH | New | OPTION CARE HEALTH INC | $1,368,000 | – | 43,457 | +100.0% | 0.45% | – |
| OMI | New | OWENS & MINOR INC NEW | $1,348,000 | – | 55,914 | +100.0% | 0.44% | – |
| PCVX | New | VAXCYTE INC | $1,255,000 | – | 52,309 | +100.0% | 0.41% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $612,000 | – | 24,352 | +100.0% | 0.20% | – |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $580,000 | -11.3% | 22,709 | -1.3% | 0.19% | -17.5% |
| ABOS | New | ACUMEN PHARMACEUTICALS INC | $555,000 | – | 55,328 | +100.0% | 0.18% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $553,000 | – | 7,915 | +100.0% | 0.18% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $524,000 | – | 14,145 | +100.0% | 0.17% | – |
| CYTK | Sell | CYTOKINETICS INC | $446,000 | -1.5% | 9,211 | -20.2% | 0.14% | -8.8% |
| MOR | New | MORPHOSYS AGsponsored ads | $344,000 | – | 68,290 | +100.0% | 0.11% | – |
| BDSX | Sell | BIODESIX INC | $165,000 | -22.9% | 130,136 | -0.5% | 0.05% | -28.0% |
| ATNX | New | ATHENEX INC | $142,000 | – | 526,651 | +100.0% | 0.05% | – |
| IMUX | Exit | IMMUNIC INC | $0 | – | -30,591 | -100.0% | -0.04% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -79,097 | -100.0% | -0.07% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -58,967 | -100.0% | -0.16% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -15,246 | -100.0% | -0.20% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -8,454 | -100.0% | -0.24% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -9,949 | -100.0% | -0.37% | – |
| ACHC | Exit | ACADIA HEALTHCARE COMPANY IN | $0 | – | -16,189 | -100.0% | -0.38% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -11,515 | -100.0% | -0.57% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -71,640 | -100.0% | -0.62% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -26,046 | -100.0% | -0.68% | – |
| XBI | Exit | SPDR SER TRs&p biotech | $0 | – | -31,349 | -100.0% | -0.82% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -31,211 | -100.0% | -0.83% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -81,007 | -100.0% | -0.91% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -27,992 | -100.0% | -0.96% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -13,300 | -100.0% | -1.31% | – |
| SIBN | Exit | SI-BONE INC | $0 | – | -430,159 | -100.0% | -1.99% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -68,305 | -100.0% | -2.03% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -32,871 | -100.0% | -2.04% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -127,656 | -100.0% | -3.10% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -126,000 | -100.0% | -3.28% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -25,900 | -100.0% | -3.43% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -418,165 | -100.0% | -5.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.